Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Wellcome Trust Considers Philadelphia for Biotech Park
Wellcome Trust, based in London, sent two officials to examine Philadelphia's scientific resources as the company searches for a site to build a planned $400 million genome research park. The final site decision has not yet been made.
Boehringer Ingelheim Expands in Petersburg
Boehringer Ingelheim Corp., headquartered in Ridgefield, Conn., has a $52 million expansion underway at its manufacturing plant in Petersburg, south of Richmond. The facility manufactures pharmaceutical compounds and ingredients for prescription drugs.
Qiagen Builds for R&D in Germantown
Qiagen, a biotech company based in the Netherlands, has plans to build a 190,000-sf R&D facility on 18 acres in Germantown. The company plans to employ more than 200 people at the new facility, which was scheduled to break ground in late March 2000.
Transkaryotic Hopes to Expand in Cambridge
Transkaryotic Therapies Inc., based in Cambridge, is examining sites in the city to build a 200,000-sf lab and office complex, in spite of an 18-month Cambridge building moratorium currently in effect.
Kaiser Plans Office in Washington
Kaiser Family Foundation, the Menlo Park, Calif.-based health care and social policy research group, expects to begin construction this summer or fall on a 300,000- to 400,000-sf facility in downtown Washington. The new building will house employees currently located at Metropolitan Square.